Methods of Clinical Treatment of a Mammal Experiencing a Viral Respiratory Infection and/or Inflammation Resulting from a Viral Respiratory Infection Using Botanical Infusion

Abstract

As described herein, the invention includes methods for the treatment of a respiratory infection of a coronavirus and/or respiratory inflammation resulting from a coronavirus infection in a mammalian individual. The method includes administering to the individual an effective amount of a water-based infusion prepared by steeping the leaves of eucalyptus globulus Labill, the root of astragalus membranaceus, and the leaves of mentha X piperita in a liquid for a time duration and administering to the patient an effective amount of the infusion. Such administration may be via an oral or an inhalable route. Also included are methods of making a composition for use in the clinical treatment of a COVID-19 (SARS-CoV-2) infection and/or to treat inflammation resulting from an is COVID-19 (SARS-CoV-2) infection comprising steeping in a liquid leaves of eucalyptus globulus Labill, roots of astragalus membranaceus, and the leaves of mentha X piperita, for a duration of time.

Dependencies are inferred from the claim text.